Complication and Assessment of Time Sensitive Tablets Involving Design Expert Software

This research investigated the creation of fast-dissolving tablets containing glipizide, utilizing a Box-Behnken design and direct compression method. The study aimed to incorporate natural super disintegrants such as Plantago ovata seed mucilage and the natural binder Guar gum, in addition to the synthetic super disintegrant cross-povidone. Detailed pre-formulation studies were carried out to verify the compatibility between glipizide and all the excipients used in the formulation. The resulting fast-dissolving tablets were thoroughly assessed for weight variation, hardness, friability, disintegration time, in vitro drug release profile, and stability. The Box-Behnken design proved to be an effective approach for optimizing the amounts of both natural and synthetic super disintegrants, with the goal of achieving quick disintegration and an optimal drug release profile. The expected result is a promising formulation of fastdissolving glipizide tablets that could greatly enhance patient compliance, particularly for diabetic patients who have trouble swallowing. This formulation has the potential to improve therapeutic effectiveness and patient ease in managing diabetes.